SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Fritz Mary Beth

(Last) (First) (Middle)
660 WHITE PLAINS ROAD

(Street)
TARRYTOWN NY 10591

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Prestige Consumer Healthcare Inc. [ PBH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP Quality & Regulatory
3. Date of Earliest Transaction (Month/Day/Year)
02/23/2024
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Rule 10b5-1(c) Transaction Indication

X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.01 per share 02/23/2024 M 12 A $57.18 15,946 D
Common Stock, par value $0.01 per share 02/23/2024 S 12 D $70 15,934 D
Common Stock, par value $0.01 per share 02/23/2024 M 11 A $30.56 15,945 D
Common Stock, par value $0.01 per share 02/23/2024 S 11 D $70 15,934 D
Common Stock, par value $0.01 per share 02/26/2024 M 5,132 A $57.18 21,006 D
Common Stock, par value $0.01 per share 02/26/2024 S 5,132 D $70.43(1) 15,934 D
Common Stock, par value $0.01 per share 02/26/2024 M 4,545 A $30.56 20,479 D
Common Stock, par value $0.01 per share 02/26/2024 S 4,545 D $70.44(2) 15,934 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Options (right to buy) $57.18 02/23/2024 M 12 (3) 05/09/2026 Common Stock 12 $0 5,441 D
Employee Stock Options (right to buy) $30.56 02/23/2024 M 11 (4) 05/06/2029 Common Stock 11 $0 5,071 D
Employee Stock Options (right to buy) $57.18 02/26/2024 M 5,132 (5) 05/09/2026 Common Stock 5,132 $0 309 D
Employee Stock Options (right to buy) $30.56 02/26/2024 M 4,545 (6) 05/06/2029 Common Stock 4,545 $0 526 D
Explanation of Responses:
1. Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $70.00 to $70.43.
2. Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $70.00 to $70.44.
3. The options vested in three installments on 1,817 shares on May 9, 2017 and 1,818 shares each on May 9, 2018 and May 9, 2019.
4. The options vested in three installments on 2,540 shares on May 6, 2020 and 2,541shares each on May 6, 2021 and May 6, 2022.
5. The options vested in three installments on 1,817 shares on May 9, 2017 and 1,818 shares each on May 9, 2018 and May 9, 2019.
6. The options vested in three installments on 2,540 shares on May 6, 2020 and 2,541shares each on May 6, 2021 and May 6, 2022
/s/ Mary Beth Fritz by William P'Pool attorney-in-fact pursuant to power of attorney dated August 7, 2018 on file with the Commission 02/27/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Primary IR Contact

Irinquiries@prestigebrands.com
Prestige Consumer Healthcare Inc.
660 White Plains Road – Ste 250
Tarrytown, NY 10591
Telephone: 914-524-6819

Transfer Agent

AST
6201 15th Avenue
Brooklyn, NY 11219
Telephone: (800) 937-5449
help@astfinancial.com
https://www.astfinancial.com

Subscribe

Stay up to date with investor news, stock information and SEC filings.
Subscribe »